Shelf Life Codigo

Country Specie Descripcion MPG MPG NY GCRS

(Months) Producto

Total
Venezuela CA Vanguard High Titer 1181603 18 0000157414 0600278
Venezuela CA Vanguard High Titer 1181603 18 0000113677 0600272
Venezuela CA Vanguard High Titer 1181603 18 0000167370 0600281
Venezuela Swine Farrowsure 1155103 18 0000119893 0600221
Venezuela Cattle Cattlemaster Gold/Pregsure 1310803 18 0000122696 0600206
Venezuela Cattle Fortress 1112103 18 0000149702 0600245
Venezuela Cattle FD Cattle Cydectin 1504603 48 0000151557 0600581
Venezuela CA Revolution 1384103 36 0000142414 0600368
Venezuela CA Revolution 1384103 36 0000142412 0600377
Venezuela Cattle Other Cattle Bios 1111303 30 0000113823 0600236
Venezuela Swine Improvac (CSL) 1253703 36 0000134714 0600224

Venezuela Swine Improvac (CSL) 1253703 36 0000134712 0600233

Venezuela CA Revolution 1384103 36 0000142416 0600374

Venezuela Swine Draxxin - Swine 1312103 36 0000106944 0600212
Venezuela Swine Excede/Naxcel CCFA (EU) - S 1225403 24 0000110016 0600341
Venezuela Swine RespiSure/Stellamune 1356703 24 0000113589 0600254
Venezuela Cattle FD Cattle Other 1505903 24 0000155879 0600791
Venezuela Swine Lutalyse-Swine 1211503 24 0000148796 0600350
 Units Units Units Units Units
SKU Description 2016 2016 2016 2016 2016
AP01 AP02 AP03 AP04 AP05

95,411 90,802 92,487 97,364 97,286

VANGUARD PLUS 5CV4L X 25 DOSES ### 31,957 31,957 31,957 31,957 31,957
Vanguard DA2L X 1 dosis (Triple Canina) ### 18,650 18,650 18,650 18,650 18,650
VANGUARD PLUS CPV X 1DS ### 13,901 13,901 13,901 13,901 13,901
FARROWSURE B X 50 DOSIS ### 609 448 528 812 582
CATTLE MASTER GOLD FP5 x25 ### 1,547 1,160 1,160 1,289 1,406
ONE SHOT ULTRA8 x 50 dosis ### 1,392 1,071 1,071 1,178 1,533
Cydectin Inj 1x500ML ### 2,547 2,547 2,547 2,547 2,547
REVOLUTION 12% X 1.0 MLX1(ROJO) ### 2,992 2,362 2,362 2,362 2,362
REVOLUTION 12% X 0.50 MLX1(CAFE) ### 2,976 2,350 2,350 2,350 2,350
LEPTOFERM-5 X 50 Dosis ### 2,093 1,569 1,572 1,744 1,758
Innosure x 250ML /125 DS ### 354 354 354 354 354

Innosure x 100ML /50 DS 219 219 219 219 219

REVOLUTION 12% X 2.0 MLX1(VERDE) ### 3,063 2,418 2,418 2,418 2,418
DRAXXIN x 100ml ### 369 150 212 298 389
EXCENEL XLA 100MG/ML 100ML ### 573 573 573 573 573
RESPISURE X 50 DS ### 2,806 2,806 2,806 2,806 2,806
Sofacal 1x500ML ### 6,011 4,049 5,588 9,689 10,468
LUTALYSE 5 mg /ml x 30 ml ### 3,352 4,218 4,218 4,218 3,013

SKU CADIVI aprobados no encontrados en este

archivo:
DRAXXIN INJ 50 ML X 1 VEN
ONE SHOT ULTRA 8 X 100 ML
Units Units Units Units Units Units Units
Units 2016
2016 2016 2016 2016 2016 2016 2016
FY
AP06 AP07 AP08 AP09 AP10 AP11 AP12

96,543 95,943 97,412 95,658 94,647 94,422 97,144 1,145,119

31,957 31,957 31,957 31,957 31,957 31,957 31,957 383,486
18,650 18,650 18,650 18,650 18,650 18,650 18,650 223,800
13,901 13,901 13,901 13,901 13,901 13,901 13,901 166,810
431 527 837 389 578 466 731 6,940
1,289 1,289 1,246 1,198 1,825 1,852 2,326 17,586
1,129 1,178 1,178 1,178 1,392 1,285 1,392 14,977
2,547 2,547 2,547 2,547 2,547 2,547 2,547 30,568
2,362 2,362 2,362 2,362 2,362 2,362 2,362 28,976
2,350 2,350 2,350 2,350 2,350 2,350 2,350 28,821
1,744 1,744 1,744 1,744 1,444 1,372 1,398 19,923
354 354 354 354 301 301 301 4,092

219 219 219 219 187 187 187 2,531

2,418 2,418 2,418 2,418 2,418 2,418 2,418 29,666

207 210 234 194 166 379 303 3,109
573 695 736 736 736 736 736 7,814
2,806 2,806 2,806 2,806 2,635 1,705 2,901 32,498
10,108 8,641 9,541 7,991 6,845 7,899 8,121 94,953
3,498 4,094 4,332 4,662 4,352 4,054 4,561 48,571
 Cantidad a Cantidad a
Cantidad a solicitar Monto Fecha
solicitar solicitar Cód AAD
(18 meses) Aprobado vencimiento
(24 meses) (>30 meses)

405,682 104,940 99,939 4,133,691

191,743
111,900
83,405
3,410 95,560 5230061 2/9/2016
7,850 315,900 5230060 2/9/2016
7,374
20,378
19,527 88,530 5230053 2/9/2016
19,423 50,830 5230051 2/9/2016
13,966 428,040 5230062 2/9/2016
2,834 318,870 5230050 2/9/2016
744,030 5230038 2/9/2016
850,320 5230037 2/9/2016
1,751 118,608 5230040 2/9/2016
98,840 5230039 2/9/2016
19,992 137,020 5230052 2/9/2016
2,067 207,480 5230057 2/9/2016
4,132 246,440 5230054 2/9/2016
19,644 68,200 5230063 2/9/2016
54,555 365,023 5230055 2/9/2016
26,609

4,214,374 Total CADIVI aprobados

(80,683) Diferencia

12,678 5230056 2/9/2016

68,005 5230064 2/9/2016
80,683
 50 -
0
0
50 1,911
25 12,636
50 -
0
0
0
50 8,561
125 2,551
125 5,952
125 6,803
50 2,372
50 1,977
0
0
0
50 1,364
0
0
USD Month 1 Month 2 Month 3 Month 4 Month 5 Month 6
Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Cost Of Sales Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Gross Margin Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Advertising and Promotion Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Field Selling Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Other Marketing Expense Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Distribution Expense 284 284 284 284 284 386
Marketing & Distribution Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
General and Administrative Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Research & Development - - - - - -
Selling, Informational & Administrative Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Amortization of Intangibles - - - - - -
Operating Expenses Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Operating Profit Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
Other (Income) and Deductions - - - - - -
Income Before Allocations Err:509 Err:509 Err:509 Err:509 Err:509 Err:509

COGS % of Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509 Err:509

GM % of Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
OPEX % of Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509 Err:509
IBA % of Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509 Err:509

Q1 Q2 Q3 Q4 FY 2016
Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509
Cost Of Sales Err:509 Err:509 Err:509 Err:509 Err:509
Gross Margin Err:509 Err:509 Err:509 Err:509 Err:509
Advertising and Promotion Err:509 Err:509 Err:509 Err:509 Err:509
Field Selling Err:509 Err:509 Err:509 Err:509 Err:509
Other Marketing Expense Err:509 Err:509 Err:509 Err:509 Err:509
Distribution Expense 852 954 1,157 1,300 4,262
Marketing & Distribution Err:509 Err:509 Err:509 Err:509 Err:509
General and Administrative Err:509 Err:509 Err:509 Err:509 Err:509
Research & Development - - - - -
Selling, Informational & Administrative Err:509 Err:509 Err:509 Err:509 Err:509
Amortization of Intangibles - - - - -
Operating Expenses Err:509 Err:509 Err:509 Err:509 Err:509
Operating Profit Err:509 Err:509 Err:509 Err:509 Err:509
Other (Income) and Deductions - - - - -
Income Before Allocations Err:509 Err:509 Err:509 Err:509 Err:509

COGS % of Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509

GM % of Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509
OPEX % of Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509
IBA % of Net Revenue Err:509 Err:509 Err:509 Err:509 Err:509
 Year
Month 7 Month 8 Month 9 Month 10 Month 11 Month 12 FY 2016 2015 LE2 %G
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 65,805 Err:509
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 19,549 Err:509
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 46,257 Err:509
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 453 Err:509
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 7,291 Err:509
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 2,927 Err:509
386 386 386 386 386 528 4,262 4,508 -5%
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 15,179 Err:509
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 476 Err:509
- - - - - - - - #DIV/0!
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 15,655 Err:509
- - - - - - - - #DIV/0!
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 15,655 Err:509
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 30,602 Err:509
- - - - - - - (112) -100%
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 30,714 Err:509

Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 29.7%

Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 70.3%
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 23.8%
Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 Err:509 46.7%
 Proposal 1
Proposal 1 LE2
Old
Revenue Err:509 24,538 65,805
COGS Err:509 5,914 19,549
GM Err:509 18,624 46,257
GM% Err:509 75.9% 70.3%

Opex Err:509 7,452 15,655

Opex % Err:509 30.4% 23.8%

Op Profit Err:509 11,172 30,602

OID - - (112)
IBT Err:509 11,172 30,714
IBT % Err:509 45.5% 46.7%